Journals Articles Conferences News About CLP
Submit a paper Email Alert
Search
Search
Articles
Journals
News
Advanced Search
Top Searches
2D MaterialsTransformation opticsQuantum PhotonicsSmall lasersSemiconductor UV PhotonicsSupersymmetric microring laser arrays

Chinese Journal of Lasers, Volume. 51, Issue 15, 1507201(2024)

Progress of Type I Organic Photosensitizers for Photodynamic Therapy

Jie Zhang1, Yonghui Pan1, Chunxu He1, Yuan Wang1, Xiaofei Miao1, Hui Zhao1, Quli Fan1、*, and Wenbo Hu2,3
Author Affiliations
  • 1State Key Laboratory of Organic Electronics and Information Displays & Institute of Advanced Materials (IAM), Nanjing University of Posts & Telecommunications, Nanjing 210023, Jiangsu , China
  • 2Frontiers Science Center for Flexible Electronics, Institute of Flexible Electronics (IFE), Northwestern Polytechnical University, Xi’an 710129, Shaanxi , China
  • 3Key Laboratory of Flexible Electronics of Zhejiang Province, Ningbo Institute of Northwestern Polytechnical University, Ningbo 315103, Zhejiang , China
    • show less
    AbstractGet PDF(in Chinese)
    Figures&Tables (13)
    Equations (0)
    References (106)
    Cited By (1)
    Tools
    Paper Information
    Topics
    References(106)

    [1] Xia C F, Dong X S, Li H et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants[J]. Chinese Medical Journal, 135, 584-590(2022).

    [2] Yang Y, Zheng X, Chen L et al. Multifunctional gold nanoparticles in cancer diagnosis and treatment[J]. International Journal of Nanomedicine, 17, 2041-2067(2022).

    [3] Fan W P, Yung B, Huang P et al. Nanotechnology for multimodal synergistic cancer therapy[J]. Chemical Reviews, 117, 13566-13638(2017).

    [4] Xu K, Zhang T, Shao J J et al. Progress of glutathione-responsive photosensitizers for tumor therapy[J]. Chinese Journal of Lasers, 50, 0307202(2023).

    [5] Almeida A, Faustino M A F, Tomé J P C. Photodynamic inactivation of bacteria: finding the effective targets[J]. Future Medicinal Chemistry, 7, 1221-1224(2015).

    [6] Dolmans D E J G J, Fukumura D, Jain R K. Photodynamic therapy for cancer[J]. Nature Reviews Cancer, 3, 380-387(2003).

    [7] Li X S, Lee S Y, Yoon J. Supramolecular photosensitizers rejuvenate photodynamic therapy[J]. Chemical Society Reviews, 47, 1174-1188(2018).

    [8] Fan W P, Huang P, Chen X Y. Overcoming the Achilles’ heel of photodynamic therapy[J]. Chemical Society Reviews, 45, 6488-6519(2016).

    [9] Foote C S. Definition of type I and type II photosensitized oxidation[J]. Photochemistry and Photobiology, 54, 659(1991).

    [10] Wang S W, Lei M. Recent advances in two-photon excited photodynamic therapy[J]. Chinese Journal of Lasers, 49, 1507101(2022).

    [11] Li B H, Chen T L, Lin L et al. Recent progress in photodynamic therapy: from fundamental research to clinical applications[J]. Chinese Journal of Lasers, 49, 0507101(2022).

    [12] Tan L C, Shen X X, He Z Q et al. The role of photodynamic therapy in triggering cell death and facilitating antitumor immunology[J]. Frontiers in Oncology, 12, 863107(2022).

    [13] Dang J J, He H, Chen D L et al. Manipulating tumor hypoxia toward enhanced photodynamic therapy (PDT)[J]. Biomaterials Science, 5, 1500-1511(2017).

    [14] Dichiara M, Prezzavento O, Marrazzo A et al. Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents[J]. European Journal of Medicinal Chemistry, 142, 459-485(2017).

    [15] Zhang Y, Zhao M, Miao J et al. Hemicyanine-based type I photosensitizers for antihypoxic activatable photodynamic therapy[J]. ACS Materials Letters, 5, 3058-3067(2023).

    [16] Huang L, Zhao S J, Wu J S et al. Photodynamic therapy for hypoxic tumors: advances and perspectives[J]. Coordination Chemistry Reviews, 438, 213888(2021).

    [17] Zhou Z J, Song J B, Nie L M et al. Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy[J]. Chemical Society Reviews, 45, 6597-6626(2016).

    [18] Li X S, Kwon N, Guo T et al. Innovative strategies for hypoxic-tumor photodynamic therapy[J]. Angewandte Chemie, 57, 11522-11531(2018).

    [19] Wang Y Y, Liu Y C, Sun H W et al. Type I photodynamic therapy by organic-inorganic hybrid materials: from strategies to applications[J]. Coordination Chemistry Reviews, 395, 46-62(2019).

    [20] Yang B W, Chen Y, Shi J L. Reactive oxygen species (ROS)-based nanomedicine[J]. Chemical Reviews, 119, 4881-4985(2019).

    [21] Cai Y, Si W L, Huang W et al. Organic dye based nanoparticles for cancer phototheranostics[J]. Small, 14, 1704247(2018).

    [22] Yao T T, Wang J, Xue Y F et al. A photodynamic antibacterial spray-coating based on the host-guest immobilization of the photosensitizer methylene blue[J]. Journal of Materials Chemistry B, 7, 5089-5095(2019).

    [23] Li M L, Xia J, Tian R S et al. Near-infrared light-initiated molecular superoxide radical generator: rejuvenating photodynamic therapy against hypoxic tumors[J]. Journal of the American Chemical Society, 140, 14851-14859(2018).

    [24] Li M L, Xiong T, Du J J et al. Superoxide radical photogenerator with amplification effect: surmounting the Achilles' heels of photodynamic oncotherapy[J]. Journal of the American Chemical Society, 141, 2695-2702(2019).

    [25] Li M L, Shao Y J, Kim J H et al. Unimolecular photodynamic O2-economizer to overcome hypoxia resistance in phototherapeutics[J]. Journal of the American Chemical Society, 142, 5380-5388(2020).

    [26] Phillips M J, Voeltz G K. Structure and function of ER membrane contact sites with other organelles[J]. Nature Reviews: Molecular Cell Biology, 17, 69-82(2016).

    [27] Li S M, Chen Y C, Wu Y P et al. An endoplasmic reticulum targeting type I photosensitizer for effective photodynamic therapy against hypoxic tumor cells[J]. Chemistry, 28, e202202680(2022).

    [28] Kamkaew A, Lim S H, Lee H B et al. BODIPY dyes in photodynamic therapy[J]. Chemical Society Reviews, 42, 77-88(2013).

    [29] Niu L Y, Guan Y S, Chen Y Z et al. BODIPY-based ratiometric fluorescent sensor for highly selective detection of glutathione over cysteine and homocysteine[J]. Journal of the American Chemical Society, 134, 18928-18931(2012).

    [30] Turksoy A, Yildiz D, Akkaya E U. Photosensitization and controlled photosensitization with BODIPY dyes[J]. Coordination Chemistry Reviews, 379, 47-64(2019).

    [31] Ye S Y, Rao J M, Qiu S H et al. Rational design of conjugated photosensitizers with controllable photoconversion for dually cooperative phototherapy[J]. Advanced Materials, 31, 1806346(2019).

    [32] Byrne A T, O’Connor A E, Hall M et al. Vascular-targeted photodynamic therapy with BF2-chelated tetraaryl-azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment[J]. British Journal of Cancer, 101, 1565-1573(2009).

    [33] Gallagher W M, Allen L T, O’Shea C et al. A potent nonporphyrin class of photodynamic therapeutic agent: cellular localisation, cytotoxic potential and influence of hypoxia[J]. British Journal of Cancer, 92, 1702-1710(2005).

    [34] Gorman A, Killoran J, O’Shea C et al. In vitro demonstration of the heavy-atom effect for photodynamic therapy[J]. Journal of the American Chemical Society, 126, 10619-10631(2004).

    [35] Killoran J, Allen L, Gallagher J F et al. Synthesis of BF2 chelates of tetraarylazadipyrromethenes and evidence for their photodynamic therapeutic behaviour[J]. Chemical Communications, 1862-1863(2002).

    [36] Wang J G, Hou Y J, Lei W H et al. DNA photocleavage by a cationic BODIPY dye through both singlet oxygen and hydroxyl radical: new insight into the photodynamic mechanism of BODIPYs[J]. ChemPhysChem, 13, 2739-2747(2012).

    [37] Lai Y C, Chang C C. Photostable BODIPY-based molecule with simultaneous type I and type II photosensitization for selective photodynamic cancer therapy[J]. Journal of Materials Chemistry B, 2, 1576-1583(2014).

    [38] Teng K X, Chen W K, Niu L Y et al. BODIPY-based photodynamic agents for exclusively generating superoxide radical over singlet oxygen[J]. Angewandte Chemie, 60, 19912-19920(2021).

    [39] Teng K X, Niu L Y, Yang Q Z. A host-guest strategy for converting the photodynamic agents from a singlet oxygen generator to a superoxide radical generator[J]. Chemical Science, 13, 5951-5956(2022).

    [40] Teng K X, Niu L Y, Yang Q Z. Supramolecular photosensitizer enables oxygen-independent generation of hydroxyl radicals for photodynamic therapy[J]. Journal of the American Chemical Society, 145, 4081-4087(2023).

    [41] Chen D P, Wang Z C, Dai H M et al. Boosting O2•- photogeneration via promoting intersystem crossing and electron-donating efficiency of aza-BODIPY-based nanoplatforms for hypoxic-tumor photodynamic therapy[J]. Small Methods, 7, 2300889(2023).

    [42] Chen D P, Yu Q, Huang X et al. A highly-efficient type I photosensitizer with robust vascular-disruption activity for hypoxic-and-metastatic tumor specific photodynamic therapy[J]. Small, 16, 2001059(2020).

    [43] Wang L F, Qian Y. Modification of a SOCT-ISC type triphenylamine-BODIPY photosensitizer by a multipolar dendrimer design for photodynamic therapy and two-photon fluorescence imaging[J]. Biomaterials Science, 11, 1459-1469(2023).

    [44] Nguyen V N, Qi S J, Kim S et al. An emerging molecular design approach to heavy-atom-free photosensitizers for enhanced photodynamic therapy under hypoxia[J]. Journal of the American Chemical Society, 141, 16243-16248(2019).

    [45] Nguyen V N, Baek G, Qi S J et al. A lysosome-localized thionaphthalimide as a potential heavy-atom-free photosensitizer for selective photodynamic therapy[J]. Dyes and Pigments, 177, 108265(2020).

    [46] Kobayashi H, Ogawa M, Alford R et al. New strategies for fluorescent probe design in medical diagnostic imaging[J]. Chemical Reviews, 110, 2620-2640(2010).

    [47] Zhang X F, Zhang J L, Liu L M. Fluorescence properties of twenty fluorescein derivatives: lifetime, quantum yield, absorption and emission spectra[J]. Journal of Fluorescence, 24, 819-826(2014).

    [48] An J, Tang S L, Hong G B et al. An unexpected strategy to alleviate hypoxia limitation of photodynamic therapy by biotinylation of photosensitizers[J]. Nature Communications, 13, 2225(2022).

    [49] Chen W L, Wang Z H, Tian M Y et al. Integration of TADF photosensitizer as “electron pump” and BSA as “electron reservoir” for boosting type I photodynamic therapy[J]. Journal of the American Chemical Society, 145, 8130-8140(2023).

    [50] Shigemitsu H, Ohkubo K, Sato K et al. Fluorescein-based type I supramolecular photosensitizer via induction of charge separation by self-assembly[J]. JACS Au, 2, 1472-1478(2022).

    [51] Shigemitsu H, Sato K, Hagio S et al. Amphiphilic rhodamine nano-assembly as a type I supramolecular photosensitizer for photodynamic therapy[J]. ACS Applied Nano Materials, 5, 14954-14960(2022).

    [52] Liu Y, Li X M, Niu X Y et al. In situ self-assembled biosupramolecular porphyrin nanofibers for enhancing photodynamic therapy in tumors[J]. Nanoscale, 12, 11119-11129(2020).

    [53] Pham T C, Nguyen V N, Choi Y et al. Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy[J]. Chemical Reviews, 121, 13454-13619(2021).

    [54] Wu M S, Liu Z Y, Zhang W A. An ultra-stable bio-inspired bacteriochlorin analogue for hypoxia-tolerant photodynamic therapy[J]. Chemical Science, 12, 1295-1301(2020).

    [55] Cui L Y, Lin Q Y, Jin C S et al. A PEGylation-free biomimetic porphyrin nanoplatform for personalized cancer theranostics[J]. ACS Nano, 9, 4484-4495(2015).

    [56] Luo T K, Ni K Y, Culbert A et al. Nanoscale metal-organic frameworks stabilize bacteriochlorins for type I and type II photodynamic therapy[J]. Journal of the American Chemical Society, 142, 7334-7339(2020).

    [57] Yang Y, Wang L, Cao H Q et al. Photodynamic therapy with liposomes encapsulating photosensitizers with aggregation-induced emission[J]. Nano Letters, 19, 1821-1826(2019).

    [58] Pucelik B, Sułek A, Drozd A et al. Enhanced cellular uptake and photodynamic effect with amphiphilic fluorinated porphyrins: the role of sulfoester groups and the nature of reactive oxygen species[J]. International Journal of Molecular Sciences, 21, 2786(2020).

    [59] Sun H, Guo R H, Guo Y H et al. Boosting type-I and type-II ROS production of water-soluble porphyrin for efficient hypoxic tumor therapy[J]. Molecular Pharmaceutics, 20, 606-615(2023).

    [60] Zhang H Y, Li W T, Tan G H et al. The anti-cancer potency of photodynamic therapy of a novel chlorin derivative Amidochlorin p6 (ACP)[J]. RSC Advances, 7, 40873-40880(2017).

    [61] Wu M S, Chen C, Liu Z Y et al. Regulating the bacterial oxygen microenvironment via a perfluorocarbon-conjugated bacteriochlorin for enhanced photodynamic antibacterial efficacy[J]. Acta Biomaterialia, 142, 242-252(2022).

    [62] Cheng J J, Zhao H T, Yao L et al. Simple and multifunctional natural self-assembled sterols with anticancer activity-mediated supramolecular photosensitizers for enhanced antitumor photodynamic therapy[J]. ACS Applied Materials & Interfaces, 11, 29498-29511(2019).

    [63] Ke Z, Xie A Z, Chen J J et al. Naturally available hypericin undergoes electron transfer for type I photodynamic and photothermal synergistic therapy[J]. Biomaterials Science, 8, 2481-2487(2020).

    [64] Li X W, Liu W M, Zheng X L et al. Lipid droplet targeting-guided hypoxic photodynamic therapy with curcumin analogs[J]. Chemical Communications, 59, 4181-4184(2023).

    [65] Hu F, Xu S D, Liu B. Photosensitizers with aggregation-induced emission: materials and biomedical applications[J]. Advanced Materials, 30, 1801350(2018).

    [66] Wang H P, Chen X, Qi Y L et al. Aggregation-induced emission (AIE)-guided dynamic assembly for disease imaging and therapy[J]. Advanced Drug Delivery Reviews, 179, 114028(2021).

    [67] Wang Y B, Shi L L, Wu W B et al. Tumor-activated photosensitization and size transformation of nanodrugs[J]. Advanced Functional Materials, 31, 2010241(2021).

    [68] Kenry, Liu B. Enhancing the theranostic performance of organic photosensitizers with aggregation-induced emission[J]. Accounts of Materials Research, 3, 721-734(2022).

    [69] Yu Y W, Jia H Y, Liu Y B et al. Recent progress in type I aggregation-induced emission photosensitizers for photodynamic therapy[J]. Molecules, 28, 332(2022).

    [70] Zhuang Z Y, Dai J, Yu M X et al. Type I photosensitizers based on phosphindole oxide for photodynamic therapy: apoptosis and autophagy induced by endoplasmic reticulum stress[J]. Chemical Science, 11, 3405-3417(2020).

    [71] Wan Q, Zhang R Y, Zhuang Z Y et al. Molecular engineering to boost AIE-active free radical photogenerators and enable high-performance photodynamic therapy under hypoxia[J]. Advanced Functional Materials, 30, 2002057(2020).

    [72] Zhao X X, Dai Y P, Ma F L et al. Molecular engineering to accelerate cancer cell discrimination and boost AIE-active type I photosensitizer for photodynamic therapy under hypoxia[J]. Chemical Engineering Journal, 410, 128133(2021).

    [73] Chen K Q, He P, Wang Z M et al. A feasible strategy of fabricating type I photosensitizer for photodynamic therapy in cancer cells and pathogens[J]. ACS Nano, 15, 7735-7743(2021).

    [74] Xiao P H, Shen Z P, Wang D L et al. Precise molecular engineering of type I photosensitizers with near-infrared aggregation-induced emission for image-guided photodynamic killing of multidrug-resistant bacteria[J]. Advanced Science, 9, 2104079(2022).

    [75] Liu Z X, Wang Q, Qiu W S et al. AIE-active luminogens as highly efficient free-radical ROS photogenerator for image-guided photodynamic therapy[J]. Chemical Science, 13, 3599-3608(2022).

    [76] Kang M M, Zhang Z J, Xu W H et al. Good steel used in the blade: well-tailored type-I photosensitizers with aggregation-induced emission characteristics for precise nuclear targeting photodynamic therapy[J]. Advanced Science, 8, 2100524(2021).

    [77] Xiao Y F, Chen W C, Chen J X et al. Amplifying free radical generation of AIE photosensitizer with small singlet-triplet splitting for hypoxia-overcoming photodynamic therapy[J]. ACS Applied Materials & Interfaces, 14, 5112-5121(2022).

    [78] Fang L P, Han M D, Zhang Y et al. Single component organic photosensitizer with NIR-I emission realizing type-I photodynamic and GSH-depletion caused ferroptosis synergistic theranostics[J]. Advanced Healthcare Materials, 12, 2300134(2023).

    [79] Yan D Y, Xie W, Zhang J Y et al. Donor/π-bridge manipulation for constructing a stable NIR-II aggregation-induced emission luminogen with balanced phototheranostic performance[J]. Angewandte Chemie, 60, 26769-26776(2021).

    [80] Li D, Chen X H, Wang D L et al. Synchronously boosting type-I photodynamic and photothermal efficacies via molecular manipulation for pancreatic cancer theranostics in the NIR-II window[J]. Biomaterials, 283, 121476(2022).

    [81] Tian B, Wang C, Zhang S et al. Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide[J]. ACS Nano, 5, 7000-7009(2011).

    [82] Hu D H, Sheng Z H, Gao G H et al. Activatable albumin-photosensitizer nanoassemblies for triple-modal imaging and thermal-modulated photodynamic therapy of cancer[J]. Biomaterials, 93, 10-19(2016).

    [83] Liang P P, Huang X Y, Wang Y et al. Tumor-microenvironment-responsive nanoconjugate for synergistic antivascular activity and phototherapy[J]. ACS Nano, 12, 11446-11457(2018).

    [84] Wang Y F, Sun Y D, Ran J B et al. Utilization of nonradiative excited-state dissipation for promoted phototheranostics based on an AIE-active type I ROS generator[J]. ACS Applied Materials & Interfaces, 14, 225-235(2022).

    [85] Guo J J, Dai J, Peng X L et al. 9, 10-phenanthrenequinone: a promising kernel to develop multifunctional antitumor systems for efficient type I photodynamic and photothermal synergistic therapy[J]. ACS Nano, 15, 20042-20055(2021).

    [86] Lü S B, Liu Y H, Zhao Y L et al. Rational design of a small organic photosensitizer for NIR-I imaging-guided synergistic photodynamic and photothermal therapy[J]. Biomaterials Science, 10, 4785-4795(2022).

    [87] Xiao P H, Xie W, Zhang J Y et al. De novo design of reversibly pH-switchable NIR-II aggregation-induced emission luminogens for efficient phototheranostics of patient-derived tumor xenografts[J]. Journal of the American Chemical Society, 145, 334-344(2023).

    [88] Yu Y W, Wu S, Zhang L et al. Cationization to boost both type I and type II ROS generation for photodynamic therapy[J]. Biomaterials, 280, 121255(2022).

    [89] Liu S S, Wang B N, Yu Y W et al. Cationization-enhanced type I and type II ROS generation for photodynamic treatment of drug-resistant bacteria[J]. ACS Nano, 16, 9130-9141(2022).

    [90] Yu Y W, Liu Y B, Chen Y T et al. Cationic AIE-active photosensitizers for highly efficient photodynamic eradication of drug-resistant bacteria[J]. Materials Chemistry Frontiers, 7, 96-105(2023).

    [91] Wu W B. High-performance conjugated polymer photosensitizers[J]. Chem, 4, 1762-1764(2018).

    [92] Wu W B, Mao D, Xu S D et al. Polymerization-enhanced photosensitization[J]. Chem, 4, 1937-1951(2018).

    [93] Hu L W, Chen Z K, Liu Y S et al. In vivo bioimaging and photodynamic therapy based on two-photon fluorescent conjugated polymers containing dibenzothiophene-S, S-dioxide derivatives[J]. ACS Applied Materials & Interfaces, 12, 57281-57289(2020).

    [94] Liu S J, Zhang H K, Li Y Y et al. Strategies to enhance the photosensitization: polymerization and the donor-acceptor even-odd effect[J]. Angewandte Chemie, 130, 15409-15413(2018).

    [95] Wang S W, Wu W B, Manghnani P et al. Polymerization-enhanced two-photon photosensitization for precise photodynamic therapy[J]. ACS Nano, 13, 3095-3105(2019).

    [96] Wu W B, Liu B. Modulating the optical properties and functions of organic molecules through polymerization[J]. Materials Horizons, 9, 99-111(2022).

    [97] Cheng J X, Zhou Y P, Xu S D et al. From main-chain conjugated polymer photosensitizer to hyperbranched polymer photosensitizer: expansion of the polymerization-enhanced photosensitization effect for photodynamic therapy[J]. Journal of Materials Chemistry B, 10, 5008-5015(2022).

    [98] Li L Q, Shao C, Liu T et al. An NIR-II-emissive photosensitizer for hypoxia-tolerant photodynamic theranostics[J]. Advanced Materials, 32, 2003471(2020).

    [99] Gu Y, Lai H J, Chen Z Y et al. Chlorination-mediated π–π stacking enhances the photodynamic properties of a NIR-II emitting photosensitizer with extended conjugation[J]. Angewandte Chemie, 62, e202303476(2023).

    [100] Wen K K, Tan H, Peng Q et al. Achieving efficient NIR-II type-I photosensitizers for photodynamic/photothermal therapy upon regulating chalcogen elements[J]. Advanced Materials, 34, 2108146(2022).

    [101] Wang Y, Li J G, Zhang Y K et al. Rational design of a meso phosphate-substituted pyronin as a type I photosensitizer for photodynamic therapy[J]. Chemical Communications, 58, 7797-7800(2022).

    [102] Jiang Q Y, Li P X, Qiu J R et al. Lysosome-targeting phenalenones as efficient type I/II photosensitizers for anticancer photodynamic therapy[J]. European Journal of Medicinal Chemistry, 255, 115418(2023).

    [103] Chen W, Zhang Y, Yi H B et al. Type I photosensitizer targeting G-quadruplex RNA elicits augmented immunity for cancer ablation[J]. Angewandte Chemie, 62, e202300162(2023).

    [104] Juvekar V, Lim C S, Lee D J et al. An azo dye for photodynamic therapy that is activated selectively by two-photon excitation[J]. Chemical Science, 12, 427-434(2020).

    [105] Lee D J, Juvekar V, Lee H W et al. Cancer-targeted azo dye for two-photon photodynamic therapy in human colon tissue[J]. Analytical Chemistry, 93, 16821-16827(2021).

    [106] Zhao J, Huang R, Gao Y et al. Realizing near-infrared (NIR)-triggered type-I PDT and PTT by maximizing the electronic exchange energy of perylene diimide-based photosensitizers[J]. ACS Materials Letters, 5, 1752-1759(2023).

    Tools

    Get Citation

    Copy Citation Text

    Jie Zhang, Yonghui Pan, Chunxu He, Yuan Wang, Xiaofei Miao, Hui Zhao, Quli Fan, Wenbo Hu. Progress of Type I Organic Photosensitizers for Photodynamic Therapy[J]. Chinese Journal of Lasers, 2024, 51(15): 1507201

    Download Citation

    EndNote(RIS)BibTexPlain Text
    Set citation alerts for article
    Save article for my favorites
    Paper Information

    Category: Optical Diagnostics and Therapy

    Received: Jan. 4, 2024

    Accepted: Jan. 30, 2024

    Published Online: Jul. 16, 2024

    The Author Email: Quli Fan (iamqlfan@njupt.edu.cn)

    DOI:10.3788/CJL240454

    CSTR:32183.14.CJL240454

    Topics

    laser devices and laser physics
    Lasers and Laser Optics
    Laser physics
    laser manufacturing
    Instrumentation, Measurement and Metrology